---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-040934"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2024-10-11T23:59:59+00:00"
generated_at: "2026-05-30T15:15:03.044005+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix receives Nasdaq delisting notice for failure to meet $1.00 bid price

## Summary
- Failed to regain compliance with $1.00 minimum bid price by Oct 7, 2024; Nasdaq notified Oct 8.
- Company will request a hearing before Nasdaq Hearings Panel, which will stay delisting action pending hearing.
- No guarantee that the Panel will grant continued listing or an extension of time to regain compliance.

## SEC filing metadata
- accession: 0001493152-24-040934
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2024-10-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315224040934/0001493152-24-040934-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315224040934/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-040934
- JSON: https://secwatch.observer/filing/0001493152-24-040934.json
- Plain text: https://secwatch.observer/filing/0001493152-24-040934.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.